Pharmacovigilance past, present and future

Season 03: episode 02

This week, Marc and Helena are joined in the podcast studio by Pav Rishiraj, Director and Head of Pharmacovigilance at Ipsen, to shed some light on this often-overlooked field of pharma.

Pav discusses his career journey in pharmacovigilance and how, in his experience, the field has changed; the importance of pharmacovigilance as a strategic enabler within businesses; and the outlook for the future of the field in terms of AI and automation.


And, in a diversion from our usual 'news you might have missed' segment, Helena leads a tribute to Her Majesty Queen Elizabeth II, touching on the key GOLD Podcast theme of inspirational leadership.


A little more on GOLD's guest...


An expert in the pharmacovigilance field, and with over 20 years of experience under his belt, Pav Rishiraj, Director and Head of Pharmacovigilance at Ipsen, has held a multitude of different positions at various pharma companies such as Merck KGaA, Sandoz and now Ipsen, across drug and patient safety. With a degree in biomedical sciences and a master of science in pharmacology, he is also currently the Chair of the ABPI Pharmacovigilance Expert Network and a Member of the International Society of Pharmacovigilance.


Additional resources


If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

Click here to subscribe to the weekly newsletter for more insights from GOLD.